Lantheus Holdings Announces Submission of Drug Master File for NM-01 in the U.S.

Thanks to the great support from our collaboration partner LMI , NanoMab has reached another milestone with this Tc-99m NM01 DMF filing with FDA after its MHRA Approval into Phase 2 trial in UK !

Lantheus’ Press Release